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performed. Under fluoroscopy, nab-rapamycin (Abraxis Bioscience) (5 or 500 μg) or
vehicle was delivered to the adventitia using a micro-infusion catheter (Mercator
MedSystems). After 28 days,the arteries were harvested. The primary outcome was
histomorphometric evidence of luminal stenosis and remodeling. Vessel injury was
scored on a validated ordinal scale.
Results: There was 100% procedural success in 16 injury sites treated with adventitial
injections. Nab-rapamycin treated vessels had significantly larger lumen (p=0.01,
ANOVA) and total vessel areas (p=0.005) indicating less negative remodeling. Percent
luminal stenosis and maximal intimal width decreased in a dose-dependent fashion.
Control vessels had significantly more fibrosis (p<0.001).
Mean values for measured and calculated metrics for 16 injured femoral
segments treated with adventitial injection of vehicle or nab-rapamycin
*p-values based on ANOVA
Conclusion: These data suggest that adventitial delivery of rapamycin decreases
luminal stenosis by inhibiting IH and preventing negative remodeling. The decreased
fibrosis in treated vessels suggests a mechanism by which rapamycin may affect vessel
remodeling following injury.
TCT-440
Allogeneic Mesenchymal Precursor Cells Reduce Infarct Size and Preserve
Cardiac Function Following Intracoronary Infusion in a Sheep Model of Acute
Myocardial Infarction
Jaco Houtgraaf1, Renate de Jong1, Kushan Kazemi1, Imo Hoefer2, Gerard
Pasterkamp2, Patrick W Serruys1, Henricus J Duckers1
1Erasmus University Medical Center, Rotterdam, Netherlands; 2University Medical
Center Utrecht, Utrecht, Netherlands
Background: Mesenchymal precursor cells (MPC) are cells that exerted therapeutic
actions in pre-clinical models of acute myocardial infarction (AMI). They are immune
privileged and can be given in an allogeneic setting. The aim of the current large animal
study was to assess the effect of intracoronary delivery of allogeneic MPC directly
following an AMI.
Methods: The 30 sheep that survived the anterior AMI were blindly randomized to
receive IC infusion of either saline (n=10) or three incremental doses of allogeneic
MPC (n=20). Cardiac function was assessed using echocardiography. After 8 weeks,
sheep were sacrificed and the hearts excised for morphometric and histological
analysis.
Results: In the control group, global LVEF deteriorated to 36.6±2.0%, whereas it was
enhanced in treated sheep to 45.4±1.4% (p= 0.009). Also regional function improved,
as fractional area change (FAC) in the apex increased by 39% in MPC-treated animals
compared to controls (p=0.027), and FAC in the mid-ventricle increased by 30%
(p=0.007). Local systolic wall thickening in the affected antero-septal wall improved
from 9.6±5.5% in controls to 39.1±1.8% in treated animals (p< 0.001) and in the
anterior wall from 13.8± 3.6% to 34.7±1.9% (p<0.001). Morphometric analysis
revealed that MPC treatment resulted in a 40% reduction in infarct size from
18.2±1.7% in control animals to only 10.9±0.6% in treated sheep (p<0.001). Also,
infarct (p<0.001) and border zone (p=0.011) thickness were enhanced in the treatment
group. Histological analysis showed an increase in blood vessel density of >50% in
the infarct (p<0.001), remote (p=0.007) and border (p<0.001) areas evoked by MPC
therapy. In addition, cardiomyocyte size was smaller in border (p<0.001) and remote
(p=0.002) areas, accompanied by reduced collagen contents, suggestive of decreased
remodeling.
Conclusion: Intracoronary delivery of allogeneic MPC directly after the AMI resulted
in preserved global and regional cardiac function, evoked by reduced infarct size,
increased perfusion and reduced remodeling.
TCT-441
Peri-adventitial Renal Artery Delivery of Guanethidine Monosulfate Attenuates
Renal Nerve Function: Preclinical Experience and Implication for Resistant
Hypertension
Christopher D Owens1, Warren J Gasper1, Serge Rousselle2, Kirk Seward3
1University of California, San Francisco, San Francisco, CA; 2Alizée Pathology,
Thurmont, MD; 3Mercator MedSystems, Inc., San Leandro, CA
Background: Renal sympathetic nerve hyperactivity contributes to resistant
hypertension. Recent innovation with catheter-based ablation of renal nerves has shown
efficacy in reducing blood pressure without procedural mortality. We hypothesize that
pharmacologic sympathectomy with guanethidine monosulfate (GNT) delivered to
renal peri-adventitial tissue would produce sustained renal artery denervation.
Methods: A micro-infusion catheter (Bullfrog®, Mercator MedSystems, Inc.) was
introduced via femoral artery into renal arteries of (N=15) swine. GNT (50 mg/6 ml,
N=12) or vehicle (6 ml, N=3) was infused to the peri-adventitia of each renal artery
under fluoroscopic guidance. Subjects were divided between a pharmacokinetic (PK)
experiment with 3 treated subjects each sacrificed at 1, 7 or 28 days, and a histology
experiment with 3 treated and 3 control subjects sacrificed at 28 days. The primary
efficacy endpoint for both experiments was kidney NE tissue content. Secondary
outcomes were plasma and tissue GNT levels, histological evidence of renal artery
denervation and renal artery injury.
Results: The 24 treated and 6 control renal arteries had 100% procedural success in
the delivery of GNT or vehicle. Histology showed optimal healing in injected renal
arteries: complete endothelialization, no thrombus formation, no or minimal non-
stenosing neointima and no or minimal medial fibrosis, with no difference between
treated and control arteries (p=NS). There was a time-dependent decrease in renal NE
content, dropping 20±16% (p=NS) by 7 days and 58±10% (p<0.024) at 28 days, each
compared to vehicle controls at 28 days. Denervation was evident from NE drops and
from histology, with reduced fiber density and endo- and peri-neurial fibrosis in GNT-
injected animals, but no neuronal changes evident in vehicle controls. PK analysis
revealed GNT retention of 54 ng/g around the renal arteries at 28 days. By contrast,
GNT plasma concentrations were below adrenergic blocking levels at 24 hours post-
injection.
Conclusion: GNT, delivered to the renal peri-adventitia resulted in a time-dependent
reduction in kidney NE content and specific immune-mediated destruction of renal
artery perivascular nerve tissue. Peri-adventitial drug delivery appears to be a safe and
efficient modality to maximize tissue concentration while minimizing plasma spillover.
TCT-442
The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in
the Porcine Mycoardial Infarction/Reperfusion Model
Piotr P Buszman1, Wojciech Wojakowski1, Krzystof Milewski1, Marcin Debinski1,
Jacek Pajak2, Wanda Jackiewicz1, Michal Jelonek1, Pawel E Buszman1, 2
1Cardiovascular Research adn Development, American Heart of Poland, Katowice,
Poland; 2Medical University of Silesia, Katowice, Poland
Background: The influence of intracoronary abciximab and bivalirudin as an
anticoagulant in ST elevation mycoardial infarction (STEMI) on myocardial salvage
and reperfusion injury (RI) is undetermined
Methods: In 23 landrace pigs STEMI was induced by the occlusion of over – the –
wire (OTW) balloon catheter in the medial left anterior descending artery for 60
minutes. In all animals bivalirudin was administred intravenously. Minutes prior to
reperfusion animals were randomized into the study group (n=11) in which 0,4 mg/kg
downstream i.c. abciximab through the central lumen of the OTW was infused, or to
the control group (n=12), in which 5 ml placebo (0,9% NaCl) was adiministred in the
same way. The control coronary angiography and ventriculography was performed
before ischaemia, 30 minutes and 48 hours after reperfusion. The animals were
sacrificed 2 days after the procedure. The infarct area (IA) and area at risk (AAR) were
marked with tetrazolinum and Evans blue respectively. The primary endpoint was the
percentage of IA in the AAR (IA/AAR%) and the left ventricle (IA/LV%).
Results: The animals in both groups were comparable with regard to sex and weight.
Hearts in the both groups had similar AAR (41,9% vs. 40,5%; p=0,7). The average
infarct size was comparable in the control and the study group as expressed by
IA/AAR% (58,1% vs 57,3%; p=0,8) and IA/LV% (28,5% vs. 26,3% p=0,5). This
corresponded well with peak troponin level (138,8 mg/ml vs. 129,8 mg/ml; p=0,59)
and hsCRP concentration (7822,5 ng/ml vs 8806,5 ng/ml; p=0,38). Furthermore the
left ventricle ejection fraction after 48 hours was also equivalent (32,2 % vs 36,5%;
p=0,21), although the decrease from baseline at 48 hours was significantly lower in
the study group (20.5 vs 29.5%, p=0.02) The enhancement of apoptosis in the AAR
was similar in both groups (16,2 vs. 15,1; p=0,07).The number of hemorrhagic
infarctions confirmed by micro and macroscopic evaluation was higher in the study
group (70% vs. 20%, p=0,05)
Conclusion: Intracoronary abciximiab with peripheral bivalirudin is not superior to
bivalirudin unaided in myocardial salvage caused by reperfusion injury in the model
of porcine ischemia/reperfusion model. This could be caused by higher number of
hemorrhagic infarcts caused by abciximab
TCT-443
Systemic and Local Tissue Pharmacokinetics of Single and Overlapping
NEVO™ Sirolimus-Eluting Stents in the Porcine Coronary Artery Model
Rami Tzafriri2, Yi-Ping Sun1, Sylvester Price1, Campbell Rogers3
1Conor Medsystems, LLC, Fremont, CA; 2CBSET, Inc, Lexington, MA; 3Cordis
Corporation, Bridgewater, NJ
Background: Preclinical safety and pharmacokinetics of the NEVO™ stent, a novel
sirolimus-eluting stent (SES) that uses bioresorbable PLGA and reservoirs (RES
TECHNOLOGY™, Cordis Corporation, NJ), have been evaluated on single stent
implants. As patients often receive multiple single or overlapping (OL) stents, we
examined the influence of overlap and sirolimus dose on the systemic and local tissue
pharmacokinetics of NEVO™ stents.
Methods: Single and OL NEVO™ stents, and OL double dose (2x) NEVO™ stents
(2.5x12 mm) were implanted in non-diseased porcine coronary arteries (n=6–
9/cohort/time point; 100% OL) for 1, 3, 8, 14, 30, or 60 days. Harvested stents, arteries,
myocardium, lung, liver, kidney, and blood (4 hours, 1, 2, 3, 5, 8, 14, 30, and 60 days
post-implant) were analyzed for sirolimus content. Abnormal tissues were evaluated
for histopathology.
Results: There were no early deaths or adverse clinical effects from OL 2x-NEVO™
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stents. Single and OL SES eluted > 90% of sirolimus loaded by Day 60. Sirolimus
elution rate and arterial content in all 3 cohorts declined quickly to similar levels by
Day 3. Though OL NEVO™ stents eluted 3.7-fold more sirolimus than single NEVO™
stents by Day 1 (28.8±7.4 vs 7.7±3.1 μg), arterial content was not statistically different,
indicating that local drug delivery to the artery wall from OL SES is dominated by the
wall-apposed stent. This inference is supported by the fact that peak sirolimus blood
level in OL NEVO™ and OL 2x-NEVO™ stents was 5.5- to 9.8-fold higher than single
NEVO™ stents (3.31±1.13 and 5.89±1.75 vs 0.60±0.27 ng/ml). Sirolimus levels in
blood, myocardium, and peripheral organs declined below the limit of quantification
by Day 60.
Conclusion: Our data show that overlapping NEVO™ stents do not influence
sirolimus elution rate and that wall apposition dominates local arterial delivery.
Systemic sirolimus exposure remains below toxic levels at all times even for OL 2x-
NEVO™ stents, presumably due to fast hydrolytic degradation of free sirolimus in
blood and hepatic metabolism.
TCT-444
Anti-inflammatory Effect of Arsenic Trioxide Eluting Stents in a porcine
coronary model
Li Shen1, Wei Yang2, Feirong Gong3, Yizhe Wu1, Juying Qian1, Aijun Sun1, Yunzeng
Zou1, Junbo Ge1
1Shanghai Institute of Cardiovascular Diseases and Cardiology Department,
Zhongshan Hospital,Fudan University, Shanghai, China; 2Department of
Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin,
China; 3Key Laboratory for Ultrafine Materials of Ministry of Education, School of
Materials Science and Engineering, East China University of Science and
Technology, Shanghai, China
Background: Previous research from our group has demonstrated trioxide (As2O3)
eluting stents (AESs) significantly reduced neointimal area and thickness compared
with bare metal stents . In the present study, we explored the anti-inflammatory effect
of As2O3 in vitro and in vivo for understanding the mechanism of AESs in reducing
in-stent restenosis.
Methods: Human dendritic cells and T lymphocytes were co-cultured with different
concentrations of As2O3. Effect of As2O3 on apoptosis, phenotypic characterization,
and cytokines production of these two kinds of inflammatory cells were evaluated by
flow cytometry and enzyme-linked immunosorbent assays. Sixty-five pigs underwent
placement of 139 oversized stents in the coronary arteries with histologic analysis,
As2O3 levels evaluation, endothelial function analysis, immunohistochemical and
western blot analysis.
Results: As2O3 induced apoptosis of human T lymphocytes and dendritic cells in a
dose-dependent manner. AESs induced less foreign body reactions of fibrin-platelet
deposition and acute inflammatory cells infiltration than BMSs and polymer-coated
stents (PCSs). There was no significant difference in extensive endothelialization and
endothelial function between AESs and BMSs after 4 weeks post stent implantation.
Stent-based As2O3 delivery effectively inhibited expression of inflammation-
associated proteins such as monocyte chemoattractant protein-1 (MCP-1) and
interleukin-6 (IL-6), in agreement with the western blotting results.
Conclusion: As2O3 eluting stents favorably modulate neointimal formation 4 weeks
after stent implantation. The quick elution of the drug from the biodegradable coating
material, less augmentation of early inflammatory reactions, and quick
endothelialization of the stent surface might contribute to the long-term safety and
efficacy.
TCT-445
Optical Characteristics of Neointimal Formation Correlate with Histological
Markers of Stent Healing in a Porcine Model of Restenosis
Jung-Sun Kim1, Maxwell E Afari1, Jinyoung Ha2, Armando Tellez1, Krzysztof
Milewski1, Gerard Conditt1, Yanping Cheng1, Greg L Kaluza1, Juan F Granada1
1Skirball Center, Orangeburg, NY; 2Harvard Medical School and Wellman Center
for Photo Medicine, Massachusetts General Hospital, Boston, MA
Background: Optical coherence tomography (OCT) has the ability to detect small
changes in peri-strut neointimal formation, however, its ability to characterize tissue
types is still limited. In this study, we aimed to compare different characteristics of in-
stent neointimal tissue in OCT with types analyzed by histology.
Methods: A total of 69 stents [39 DES and 30 BMS] were implanted in coronary
arteries of 27 swine. By OCT, neointimal type was classified as homogeneous,
heterogeneous or layered pattern according to its pattern of backscatter and optical
density. These resulting optical patterns were correlated with histological findings
(external elastic lamina (EEL) disruption, significant fibrin deposition, circumferential
rim of peri-strut inflammatory cell infiltration and collagen deposition) in every cross-
section (CS).
Results: A total of 197 OCT and histological CS were well matched. The
heterogeneous (0.44±0.21mm) and layered (0.65±0.16mm) patterns had a significantly
higher degree of neointimal thickness compared to the homogeneous pattern
(0.25±0.16 mm, p<0.001). Collagen deposition was more frequently present in the
homogeneous pattern (72%), whereas significant fibrin deposits were more commonly
seen in the heterogeneous pattern (57%). Peri-strut inflammation was less frequently
found in the homogeneous pattern (19.8%) in comparison to the layered (73.9%) or
heterogeneous patterns (43.1%). Presence of EEL rupture behaved similarly (73.9%
in layered, 46.6% in heterogeneous, 22.4% in homogeneous pattern). Optical density
analyses showed that the homogeneous pattern had the narrowest standard deviation
(0.09±0.10 vs. 0.26±0.22 in heterogeneous and 0.42±0.24 in layered pattern) and the
highest mean value (105.9±17.6 vs. 83.0±17.1 in heterogeneous and 84.0±12.9 in
layered pattern).
Conclusion: The optical characteristics of neointimal formation seen in OCT properly
correlated with the presence of several histological findings involved in stent healing.
The biological implications of these findings in clinical outcomes require further
investigation.
TCT-446
Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary
stents in a porcine model
Li Shen1, Qibing Wang1, Yizhe Wu1, Jian Xie2, Junbo Ge1
1Shanghai Institute of Cardiovascular Diseases and Cardiology Department,
Zhongshan Hospital, Shanghai, China, Shanghai, China; 2Shandong Huaan
Biotechnology Co., Ltd,, Laiwu, China
Background: Conventional metallic, drug-eluting stents (DES) restrict restenosis after
percutaneous coronary intervention (PCI). However, stents can generate additional
foreign body reactions and consequently increase the possibility of adverse
events.Bioresorbable polymeric scaffolds have been suggested as a possible solution.
In this study, short-term effects of fully bioabsorbable sirolimus-loaded poly-l-lactic
acid (PLLA) stents (Xinsorb) were evaluated in a porcine coronary model to assess
the technical feasibility, biocompatibility, and effects on coronary stenosis.
Methods: PLLA stents (Xinsorb, Huaan Biotechnology Co., Ltd, China) were coated
with 140 μg/cm2 of sirolimus. Commercially available sirolimus-eluting stents (Excel,
JW Medical System, China) were used as controls. Xinsorb stents (n=16) and Excel
stents( n=16) were randomly implanted in porcine coronary arteries. Neointima
formation was measured by angiography and histomorphometry at 30 and 90 days.
Additionally,inflammation score and endothelial cell recovery were measured.
Results: The Xinsorb stents can be delivered and expanded at high pressure compared
with Excel stents, without any fracture and acute recoil. Both had a remarkable effect
on reducing neointimal hyperplasia,since no distinctive vessel narrowing greater than
50% were observed by angiography.By histomorphometry,at 30 and 90 days, coronary
stenosis was 18.6 ± 5.2 vs. 21.4 ± 7.2% and 24.5 ± 4.7 vs. 27.7 ± 5.6% respectively (p
> 0.05), after Xinsorb and Excel stent implantations. The inflammation scores were
0.84 ± 0.15 vs. 0.74 ± 0.10 and 0.93 ± 0.26 vs. 0.88 ± 0.10, respectively (p > 0.05). At
90 days, through scanning electron microscopy, Xinsorb and Excel stents were all
completely endothelialized, though they mildly delayed reendothlialization at 30 days.
Conclusion: Xinsorb stents reliably supported blood vessels and favourably modulated
neointimal formation at least at 90 days in a porcine coronary model. No safety
concerns regarding inflammatory reactions and in-stent thrombosis were observed.The
long-term safty and efficacy of the stents will be validated.
TCT-447
Angiographic and Histological Response Following Implantation of a Novel
Stent-On-A-Wire in the Animal Model
Roberto Diletti1, Hector M Garcia-Garcia1, Lynn Bailey2, Serge Rousselle3, Gregory
Kopia4, William Easterbrook5, Mark Pomeranz5, Patrick Serruys1
1Interventional Cardiology, Erasmus MC, Rotterdam, Netherlands; 2CBSET Inc.
USA, Lexington, MA; 3Alizee Pathology, Thurmont, MD; 4Kopia Consulting,
Hillsborough, NJ; 5Svelte Medical Systems,, New Providence, NJ
Background: The Svelte Stent-on-a-Wire (SOAW) is a thin strut novel device
consisting of a balloon expandable cobalt chromium stent premounted onto a single
lumen fixed-wire delivery catheter platform. We evaluated the performance of the novel
Svelte Stent-on-a Wire, in comparison with the MultiLink Vision (ML Vision) balloon
expandable stent, in porcine coronary arteries.
Methods: Eight Yorkshire swine (30-day follow-up cohort) and 7 Yucatan mini-swine
(90-day follow-up cohort) were implanted with either Svelte SOAW or control ML
Vision. Acute performance characteristics were graded by interventionalists during
implantation. Angiographic assessments were performed at the index procedure and
at 30 or at 90 days post-implantation. Scanning electron microscopy (SEM) histological
and histomorphometric analysis of stented segments were performed after angiographic
follow-up.
Results: Acute implantation performance was similar between the 2 stents however
deflation time was significantly lower in the Svelte SOAW group (9.56±0.96 s vs
4.70±0.93 s, p < 0.05). Angiographic late loss was similar for both stents at 30
(0.83±0.59 mm vs 0.88±0.71mm, p=0.969) and at 90 days (0.76±0.35 mm vs
0.83±0.35 mm, p=0.679). SEM analysis showed complete endothelialization at 30 days
in both stent types. The presence of inflammatory cells was minimal and equivalent
for both stent treatments at both time points. There was no in-stent thrombus in either
stent group. Histopathological assessment demonstrated minimal injury and equivalent
inflammation at 30 and 90 days with Svelte SOAW and ML Vision stents as well as
endothelialization, neointimal maturation, adventitial fibrosis and neointimal fibrin.
Histomorphometric analysis showed no differences between the 2 groups in stent,
lumen, media or neointimal areas at either 30 or 90 days post-implantation.
Conclusion: At 30 and 90 days after implantation in porcine coronary arteries, the
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